Related Experiment Video

Updated: Mar 28, 2026

Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model
10:23

Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model

Published on: November 13, 2012

14.2K

Identification of a small molecule that downregulates MITF expression and mediates antimelanoma activity in vitro

Chuan Cheng1, Hui-Wen Yang, Jin-Feng Shang

  • 1aState Key Laboratory of Biotherapy and Cancer Center, West China Hospital, West China Medical School, Sichuan University bState Key Laboratory Breeding Base of Systematic Research Development and Utilization of Chinese Medicine Resources, Sichuan Province and Ministry of Science and Technology, Chengdu, Sichuan cDepartment of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi'an, China.

Melanoma Research
|December 20, 2015
PubMed

Insights

A novel compound, SKLB226, effectively inhibits melanoma cell growth and migration by downregulating MITF mRNA. This discovery offers a promising new lead for developing effective antimelanoma therapies.

Area of Science:

  • Oncology
  • Developmental Biology
  • Pharmacology

Background:

  • Melanoma, a cancer of melanocytes, lacks effective treatments for metastatic stages.
  • There is a critical need for novel therapeutic agents to combat advanced melanoma.
  • Understanding melanocyte development is key to identifying new therapeutic targets.

Purpose of the Study:

  • To identify novel antimelanoma agents using a zebrafish embryonic pigmentation model.
  • To investigate the mechanism of action of identified compounds.
  • To evaluate the potential of lead compounds as therapeutic leads for melanoma.

Main Methods:

  • Screening of an in-house small molecule library using a zebrafish pigmentation assay.
  • Assessment of pigment cell migration and MITF mRNA levels in zebrafish embryos and mammalian melanoma cells.
  • Evaluation of cell viability and migration in mammalian melanoma cell lines.

Main Results:

  • The small molecule compound SKLB226 was identified as an inhibitor of zebrafish pigmentation and pigment cell migration.
  • SKLB226 demonstrated downregulation of Microphthalmia-associated Transcription Factor (MITF) mRNA in both zebrafish and mammalian melanoma cells.
  • SKLB226 significantly suppressed the viability and migration of mammalian melanoma cells.

Conclusions:

  • SKLB226 serves as a valuable chemical tool for studying melanocyte development.
  • SKLB226 is a promising lead compound for the development of new antimelanoma therapies.
  • Further structural optimization of SKLB226 is warranted to enhance its therapeutic potential.

More Related Videos

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

3.0K
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.9K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.6K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
3.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K